EU drug regulator begins real-time review of Sinovac’s Covid-19 vaccine

EU drug regulator begins real-time review of Sinovac’s Covid-19 vaccine
EU drug regulator begins real-time review of Sinovac’s Covid-19 vaccine

Hello and welcome to the details of EU drug regulator begins real-time review of Sinovac’s Covid-19 vaccine and now with the details

Nevin Al Sukari - Sana'a - The EU is still assessing the Sinovac vaccine after human and animal trials. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


BRUSSELS, May 4 — Europe’s medicines regulator said today it has started a real-time review of Sinovac’s Covid-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus.

Data on the vaccine, Covid-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed-up potential approvals, the European Medicines Agency said. — Reuters

These were the details of the news EU drug regulator begins real-time review of Sinovac’s Covid-19 vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV UN chief and senior officials express deep concern over East Jerusalem violence
NEXT Bahrain's national carrier to airlift medical supplies to help India combat coronavirus